Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Sci Rep 6 , 35306 (2016)
Protocols using 'bargain' peptides from unverified sources produce inconsistent outcomes that can't be replicated
Related compounds Same research category.
READ the full study in RAPM: #PhantomLimbPain #Cryoneurolysis #PainMedicine #RegionalAnesthesia #ClinicalResearch #Innovation To view or add a comment, sign in Ophthopedia Update:Mitomycin C in Non-Endoscopic Endonasal Dacryocystorhinostomy: A Randomized Clinical Trial involving 442 cases: Mitomycin C (MMC) is used as an adjuvant in endonasal endoscopic dacryocystorhinostomy (EN-DCR) despite the existing heterogeneity in the literature on the concentration, duration of application, indication and outcomes
US$ 22.83
US$ 20.53
US$ 27.17
